BioSpace News Archive

Today, the Global Down Syndrome Foundation (GLOBAL) announced that their lead Alzheimer’s scientist and colleagues were awarded a $4.6 million, five-year grant by the National Institutes of Aging to study whether a potential Alzheimer’s disease treatment is safe and effective in improving cognition function in young adults with Down syndrome.

Cue Biopharma, Inc. announced today the publication of a research study titled “ T-Cell Receptor-specific Immunotherapeutics Drive Selective In vivo HIV and CMV- specific T-Cell Expansion in Humanized Mice ” in the peer-reviewed Journal of Chronic Infectious Diseases.

Shionogi Presents the Results of COVID-19 Therapeutic Agent at ISIRV-WHO Virtual Conference

Horizon Therapeutics plc (Nasdaq: HZNP) today announced additional data supporting the long-term efficacy of TEPEZZA for the treatment of TED.

Lucid Diagnostics Inc. a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc., announced the appointment of highly accomplished molecular biologist Suman M. Verma, M.D., Ph.D. as Lucid’s Chief Scientific Officer and PAVmed’s VP, Molecular Diagnostics.

Throughout the pandemic, the Government of Canada has worked closely with vaccine manufacturers to negotiate the delivery of vaccines to Canada as quickly as possible.

Ernest Pharmaceuticals and the Forbes Lab at UMass/Amherst developed a salmonella-based cancer therapy that selectively invades cancer cells, then produces and delivers a cancer drug to kill the tumor.

Johnson & Johnson announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2021 of $1.06 per share on the company’s common stock.

Puma Biotechnology, Inc., a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, Nov. 4, 2021, following the release of its third quarter 2021 financial results.

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation cancer immunotherapies, will host its third quarter 2021 corporate update conference call and live audio webcast on Thursday, October 28th at 8:30 a.m. E.T.